The Food and Drug Administration grants emergency use authorization to Pfizer antiviral COVID-19 oral pill named Paxlovid for at-risk people aged above 12 years, becoming the first oral treatment to be approved.
The Food and Drug Administration grants emergency use authorization for Pfizer's antiviral COVID-19 oral pill named Paxlovid for at-risk people overtheage of 12 years, becoming the first at-homeoral treatment to be approvedbytheFDA.
